Active traders and day traders have many stocks to choose from this Friday morning. We are tracking news and moves in shares of Acorda Therapeutics, Inc. (NASDAQ: ACOR), Biosante Pharmaceutical, Inc. (NASDAQ: BPAX), Opnext, Inc. (NASDAQ: OPXT), and Popular, Inc. (NASDAQ: BPOP).
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is up more than 22% on heavy volume to $32.79, relative to a 52-week range of $20.43-$37.91. European regulators recently reversed their earlier decision and have approved the company’s multiple-sclerosis treatment drug.
Biosante Pharmaceutical, Inc. (NASDAQ: BPAX) is up more than 6% premarket to $2.60, relative to a 52-week range of $1.29-$2.69.
Opnext, Inc. (NASDAQ: OPXT) is up more than 19% premarket to $2.23, relative to a 52-week range of $1.29-$4.45. The company turned a 4Q profit in its report after market close yesterday.
Popular, Inc. (NASDAQ: BPOP) is down more than 6% on heavy volume to $2.85, relative to a 52-week range of $2.37-$3.59.
Travel Cards Are Getting Too Good To Ignore (sponsored)
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.